Sheba Medical Center ( Site 0200)

Ramat Gan 5265601

2 studies enrolling now · 3 studies all time

What they study most

Malignant Neoplasm, Metastatic Neoplasm, Ovarian Cancer Recurrent

Studies at this site

• A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003) — Recruiting now
• A Clinical Study of MK-8294 in Participants With Advanced Solid Tumors (MK-8294-001) — Recruiting now
• A Study of MK-4700 Alone or With Pembrolizumab in Participants With Advanced or Metastatic Solid Tumors (MK-4700-001) — Completed